Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagaa catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
JC263445.1 | emblrelpat | Sequence 129 from Patent EP2326709. | 8286 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
JC953346.1 | emblrelpat | Sequence 99 from Patent EP2687596. | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LF708115.1 | emblrelpat | JP 2016154537-A/20: Serum-Free Stab... | 4920 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LF708369.1 | emblrelpat | JP 2016155836-A/3: MODIFIED FACTOR ... | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LG005174.1 | emblrelpat | KR 1020150014440-A/53: LENTIVIRAL V... | 9020 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LG005176.1 | emblrelpat | KR 1020150014440-A/55: LENTIVIRAL V... | 8549 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LG065089.1 | emblrelpat | KR 1020110057131-A/41: Recombinantl... | 4920 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LG078998.1 | emblrelpat | KR 1020150067772-A/151: Modified fa... | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LQ294785.1 | emblrelpat | Sequence 6 from Patent WO2016061286. | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MO332298.1 | emblrelpat | Sequence 53 from patent US 10391157. | 9020 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
LQ515548.1 | emblrelpat | Sequence 99 from Patent EP3064580. | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MO332300.1 | emblrelpat | Sequence 55 from patent US 10391157. | 8549 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
MA989217.1 | emblrelpat | JP 2018046860-A/7: LENTIVIRAL VECTO... | 9020 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MA989219.1 | emblrelpat | JP 2018046860-A/9: LENTIVIRAL VECTO... | 8549 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MD430762.1 | emblrelpat | JP 2019058173-A/20: Serum-Free Stab... | 4920 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MP712699.1 | emblrelpat | Sequence 356 from Patent EP3679137. | 5251 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MP921572.1 | emblrelpat | Sequence 99 from Patent WO2021030787. | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
DI213353.1 | emblrelpat | KR 1020110008084-A/99: FACTOR VII P... | 4278 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI240848.1 | emblrelpat | KR 1020120050480-A/1638: ANTIBODIES... | 6822 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DJ341132.1 | emblrelpat | TUMOR MODELS EMPLOYING GREEN FLUORE... | 4196 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.